Interleukin-4 (IL-4) is a pivotal component in the regulatory network of cytokine which orchestrate immune and inflammatory responses. Activities by this molecule have been implicated in many beneficial immune mechanisms, including protection against parasitic helminth infections. However, IL-4 is best known for the pivotal role it plays in the pathophysiology of atopic diseases. The molecular processes which control cellular expressions of this cytokine remain unresolved, although evidence now implicated the transcription factors STAT6, c-Maf an dNIP45 as being required to promote IL-4 production. We have recently uncovered a novel regulatory pathway involving Neu-1, a sialidase encoded within the Neu-1 locus of the murine MHC. Activities by Neu-1 appear to be necessary for initiating IL-4 gene expression by activated T-cells. Using molecular tools made available from the recent cloning of murine neu-1, we will explore the processes which control Neu-1 gene expression by T-cells, plus the mechanisms which allow this sialidase to modulate production of IL-4. We will investigate the requirement for Neu-1 production by T-cells following activation and also plan to characterize the promoter region of neu-1 to gain information about the transcription factors which control expression of this gene. Modulatory influences by Neu-I on signaling events through the IL-4R, as well as changes in c-Maf and NIP45 expression and activities will be carefully analyzed. We have recently determined that the monosialylated ganglioside GM3 represents a membrane associated target for Neu-1 and could be involved in the regulatory influences by Neu-1 on cytokine production. Influences by GM3 seem to reside upstream of TCR-stimulated calcium signaling, since IL-4 produced in response to ionomycin or thapsigargin exposure is refractory to GM3 regulation. Mechanisms responsible for the counterregulatory influences by GM3, the major ganglioside on T-cell plasma membranes will be explored. How GM3 influences calcium signaling events, as well as its potential to negatively regulate STAT6, C-Maf or NIP45 expression or activities will be studied. Finally, we will evaluate the use of GM3 in vivo, as a strategy to selectively inhibit IgE production in immunized animals.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA025917-20
Application #
6149959
Study Section
Immunobiology Study Section (IMB)
Program Officer
Finerty, John F
Project Start
1979-08-01
Project End
2003-01-31
Budget Start
2000-02-01
Budget End
2001-01-31
Support Year
20
Fiscal Year
2000
Total Cost
$208,835
Indirect Cost
Name
University of Utah
Department
Pathology
Type
Schools of Medicine
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Zhang, Tian Y; Ding, Xiaohong; Daynes, Raymond A (2005) The expression of 11 beta-hydroxysteroid dehydrogenase type I by lymphocytes provides a novel means for intracrine regulation of glucocorticoid activities. J Immunol 174:879-89
Jones, Dallas C; Ding, Xiaohong; Zhang, Tian Y et al. (2003) Peroxisome proliferator-activated receptor alpha negatively regulates T-bet transcription through suppression of p38 mitogen-activated protein kinase activation. J Immunol 171:196-203
Daynes, Raymond A; Enioutina, Elena Y; Jones, Dallas C (2003) Role of redox imbalance in the molecular mechanisms responsible for immunosenescence. Antioxid Redox Signal 5:537-48
Enioutina, Elena Y; Visic, Dino M; Daynes, Raymond A (2002) The induction of systemic and mucosal immunity to protein vaccines delivered through skin sites exposed to UVB. Vaccine 20:2116-30
Jones, Dallas C; Manning, Bernadette M; Daynes, Raymond A (2002) A role for the peroxisome proliferator-activated receptor alpha in T-cell physiology and ageing immunobiology. Proc Nutr Soc 61:363-9
Jones, Dallas C; Ding, Xiaohong; Daynes, Raymond A (2002) Nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) is expressed in resting murine lymphocytes. The PPARalpha in T and B lymphocytes is both transactivation and transrepression competent. J Biol Chem 277:6838-45
Heithoff, D M; Enioutina, E Y; Daynes, R A et al. (2001) Salmonella DNA adenine methylase mutants confer cross-protective immunity. Infect Immun 69:6725-30
Manning, B M; Enioutina, E Y; Visic, D M et al. (2001) CpG DNA functions as an effective adjuvant for the induction of immune responses in aged mice. Exp Gerontol 37:107-26
Enioutina, E Y; Visic, V D; Daynes, R A (2000) Enhancement of common mucosal immunity in aged mice following their supplementation with various antioxidants. Vaccine 18:2381-93
Chen, X P; Ding, X; Daynes, R A (2000) Ganglioside control over IL-4 priming and cytokine production in activated T cells. Cytokine 12:972-85

Showing the most recent 10 out of 69 publications